o2h Discovery

o2h Discovery is a privately held, revenue-generating contract research organization founded in 2003, providing comprehensive small molecule drug discovery services. Its integrated platform combines medicinal chemistry, computational chemistry, chemical biology, and expertise in novel modalities like PROTACs and oligonucleotides, supported by a proprietary 'Chemistry in the Cloud' technology platform. The company partners with a range of global biotech and pharma firms, offering flexible collaboration models to accelerate client programs from target validation to lead optimization.

Integrated drug discovery platform featuring the proprietary 'Chemistry in the Cloud' app-based collaboration platform, combined with broad medicinal chemistry, computational chemistry (virtual screening, molecular modeling), and expertise in modern modalities (PROTACs, molecular glues, peptides, oligonucleotides).

o2h Discovery competes in a fragmented market with large, full-service CROs (e.g., Charles River, Labcorp), specialized chemistry CROs (e.g., Sygnature, Evotec), and numerous smaller regional players. Its differentiation lies in its integrated platform, focus on collaboration, expertise in novel modalities, and its unique 'Chemistry in the Cloud' technology.